Cilostazol Tablet
Product Images NDC 50268-177

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 50268-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A pharmacokinetic line graph showing plasma concentration (ng/mL) of cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol over 24 hours. The x-axis represents time in hours, and the y-axis shows plasma concentration, with concentration decreasing for all compounds over time.*

FDA Label Image

Figure2.jpg (Figure2)

A bar chart comparing percent mean improvement in maximal walking distance for placebo, cilostazol 50 mg twice daily, and cilostazol 100 mg twice daily across multiple clinical trials of different durations (12 to 24+ weeks). The chart shows higher improvement percentages generally seen with cilostazol 100 mg b.i.d. compared to placebo and cilostazol 50 mg b.i.d.*

FDA Label Image

Label 1 (Screen Shot 2016 10 18 At 10.12.15 Am)

Packaging label for cilostazol Tablets USP 50 mg oral tablets by AvPAK. The label shows a quantity of 50 tablets in unit dose packaging, with storage instructions, usual dosage advice, and manufacturer information including location in Pulaski, TN. The NDC is 50268-176-15.*

FDA Label Image

Label 2 (Screen Shot 2016 10 18 At 10.12.43 Am)

cilostazol Tablets USP 100 mg oral tablet label showing the product name, strength, quantity of 50 tablets in unit dose packaging, Rx only status, manufacturer AvPAK, and dosing/storage instructions in small print. The label includes the NDC code 50268-177-15 and barcode.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of cilostazol, showing its molecular framework with characteristic rings and side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.